Coronavirus FDA

U.S. faces final step in race to give Pfizer’s coronavirus vaccine the green light

Reading now: 228
globalnews.ca

Pfizer’s COVID-19 vaccine faces one final hurdle as it races to become the first shot greenlighted in the U.S.: a panel of experts who will scrutinize the company’s data for any red flags.Thursday’s meeting of the Food and Drug Administration’s vaccine advisory panel is likely the last step before a U.S.

decision to begin shipping millions of doses of the shot, which has shown strong protection against the coronavirus.The FDA panel functions like a science court that will pick apart the data and debate — in public and live-streamed — whether the shot is safe and effective enough to be cleared for emergency use.

The non-government experts specialize in vaccine development, infectious diseases and medical statistics. The FDA is expected to.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA